For example, an isoflavone anti-cancer agent, ME-344, can bind to HO-1 and promote HO-1 translocation from the SER to the mitochondria, where it alters mitochondrial protein profiles, leading to an interference in tumor cell redox homeostasis and mitochondrial function [71]. The gene discussed is HMOX1; the disease is cancer.